Abstract
The prevalence of metabolic syndrome is increasing in African populations, and is particularly high in Black South African women (42%) vs women in the United Kingdom (23%) and the United States of America (36%). This population group is also known to have the highest prevalence of obesity in the sub-Saharan African region (42%), and consequently, a high risk of non-communicable diseases. In this article, we discuss factors (abdominal subcutaneous fat, visceral fat, lean mass, adiponectin, leptin, vitamin D, smoking and menopausal status) that have been investigated for their possible association with metabolic syndrome in African women, and discuss some recommendations for management of the syndrome. In particular, the infrastructural development of HIV/AIDS clinics in South Africa provides an ideal integrated platform to cater to the treatment needs of patients with multiple chronic morbidities.
Keywords: Metabolic Syndrome, South Africa, Women
Introduction
A large proportion of South African women of African ethnicity live in urban areas and have a high prevalence of obesity and related cardiometabolic diseases.1,2 This has resulted in an increasing presence of metabolic syndrome (MetS) in Black South African women,2-4 comparable to results found through studies of other African women,2,5 and higher than most developing Asian countries and developed European countries (Table 1).6 Most African countries have a higher prevalence of MetS in women than men (Table 1). When compared with rural Black African populations, an estimated 13.6% more women present with MetS in the urban setting,3 which may be due to the higher prevalence of obesity associated with the urban environment.7-9
Table 1. Prevalence of metabolic syndrome in selected developed countries.
Reference | Criteria used | Study design | N | Age,a years | Country | MetS prevalence | |
Male % | Female % | ||||||
Aguilar et al10 | Modified NCEP | NHANES, 2003-12; Cross-sectional | 1,931 | ≥20 | United States (MetS prevalence per ethnic group: African American, 33.0%; Hispanic, 35.0%; Non-Hispanic Whites, 33.0%) | 30.3 | 35.6 |
Khan and Jackson11 | Harmonized | Cross-sectional (urban) | 1,403 | 20-68 | United States (South Asian Americans) | 47.0 | 54.0 |
Tillin et al12 | Modified NCEP | Cross-sectional (urban) | 4,860 | 40-69 | United Kingdom | ||
African Caribbeans | 15.5b | 23.4 b | |||||
Europeans | 18.4 b | 14.4b | |||||
South Asians | 28.8 b | 31.8 b | |||||
Villegas et al13 | Modified NCEP | Cross-sectional (urban) | 890 | 50-69 | Ireland | 21.8 | 21.5 |
Jeppesen et al14 | Modified NCEP | Cross-sectional (urban) | 2,493 | 41-72 | Denmark | 18.6 | 14.3 |
Cameron et al15 | IDF | Cross-sectional (population- based) | 6,072 | 50.5 ± 11.7 | Australia | 39.2 | 27.9 |
Bo et al16 | Modified NCEP | Cross-sectional (urban) | 1,877 | 45-64 | Italy | 24.1 | 23.1 |
a. Age range or mean age of participants as provided by the respective journal articles.
b. Age-adjusted MetS prevalence used.
NHANES, National Health and Nutrition Examination Survey; NCEP, National Cholesterol Education Program; IDF, International Diabetes Federation.
Most of the studies conducted in sub-Saharan Africa on the epidemiology and etiology of MetS have occurred in South Africa, and this country, like the rest of Africa is progressing through a nutrition transition with rising levels of obesity and non-communicable diseases (NCD).35 Therefore, the purpose of this qualitative systematic review was to describe the epidemiology of MetS across Africa and to review data from South Africa on the demographic, behavioral and physiological factors that contribute to the development of MetS as these may be applicable to other African countries. The higher prevalence of obesity and MetS in African women and the greater number of studies in females than males are the principal reasons for focussing on MetS in women.
Epidemiology of Metabolic Syndrome
The data in Tables 1, 2, 3 and 4 compare the prevalence of MetS in males and females across studies conducted in different countries. The studies from non-African countries were chosen based on the use of recognized criteria for diagnosing MetS, the reporting of prevalence data in both males and females and large representative samples from rural and/or urban populations. The studies from African nations were chosen using similar criteria, but due to the small number of studies, the sample size was reduced to ≥100 participants and prevalence data for MetS had to be present for females. It should be noted that the aim of Tables 1, 2, 3 and 4 is to display an overview of the prevalence of MetS in various populations, with a key emphasis on African and South African studies. Data from the United States show ethnic differences in MetS prevalence with South Asians having a higher prevalence compared with the other groups,10,11 which is confirmed by data from the United Kingdom (Table 1).12 In India21 and Bangladesh20 the prevalence of MetS is similarly high, especially in females (Table 2), while in South Asians living in South Africa the prevalence is higher in males compared with females (Table 4).34 In European countries the prevalence of MetS differs little between sex (Table 1), while in Australia a large population study showed a much higher prevalence in males than females (Table 1),15 a pattern also observed from studies in South Korea17 and Turkey (Table 2).22 A meta-analysis of 35 studies from mainland China, including both rural and urban populations, showed a higher prevalence of MetS in females than males.18 A study from 7 cities across South America showed a similar prevalence of MetS in males and females, with the total prevalence levels varying from 14% in Ecuador to 27% in Mexico.22 Data from African studies show a range of prevalence levels that are comparable with data from the developed world, particularly for urban-dwelling South African women (Table 3). The prevalence of MetS is consistently higher in African females when compared with males, with the exception of one study from Nigeria (Table 3).27 In comparison, data from developed nations show similar prevalence levels between males and females of European ancestry or higher levels in males. These data are comparable to obesity trends in developed, compared with African, nations where in the latter countries, obesity is far more prevalent in females than males,36,37 a trend that is not seen in the former countries.38 The very high prevalence of MetS in type 2 diabetic patients is confirmed by the studies of Kenge et al26 and Kalk and Joffe.32 It should be noted that when comparing the prevalence of MetS across studies, some of the differences observed may be due to the different age ranges used in each study and also the different diagnostic criteria used for MetS.
Table 2. Prevalence of metabolic syndrome in selected developing non-African countries.
Reference | Criteria used | Study design | N | Age,a years | Country | MetS prevalence | |
Male % | Female % | ||||||
Kim17 | Modified NCEP | Cross-sectional (urban) | 11,810 | ≥45 | South Korea | 53.2 | 35.7 |
Li et al18 | IDF | Meta-analysis of 35 papers (rural, urban) | 226,653 | ≥15 | China | 19.2 | 27.0 |
Bhowmik et al19 | IDF | Cross–sectional (rural) | 2,293 | ≥20 | Bangladesh | 19.2b | 27.5b |
Deepa et al20 | Modified NCEP | Cross-sectional (urban/rural) | 1,123 | >20 | India | 23.0 | 40.0 |
Ozsahin et al21 | Modified NCEP | Cross–sectional (urban) | 1,637 | 20–79 | Adana, Turkey | 23.7 | 39.1 |
Escobedo et al22 | Modified NCEP | Cross-sectional (urban) | 11,550 | 25-64 | South America (Prevalence per country: Mexico, 27%; Venezuela, 26%; Chile, 21%; Columbia, 20%; Peru, 18%; Argentina, 17%; Ecuador, 14%) | 20.0 | 22.0 |
a. Age range or mean age of participants as provided by the respective journal articles.
b. Age-adjusted MetS prevalence used.
NCEP, National Cholesterol Education Program; IDF, International Diabetes Federation.
Table 3. Prevalence of metabolic syndrome in African countries.
Reference | Criteria used | Study design | N | Age,a years | Country | MetS prevalence | |
Male % | Female % | ||||||
Akintunde et al23 | IDF | Cross-sectional (urban) | 140 | 55.1 ± 10.8 | Osogbo, Nigeria | 23.0 | 37.0 |
Tran et al24 | IDF | Cross-sectional (urban) | 1,935 | ≥24 | Addis Ababa, Ethiopia | 14.0 | 24.0 |
Assah et al25 | Modified NCEP | Cross-sectional (urban/rural) | 552 | 25-55 | Cameroon | 7.0b | 25.0b |
Kengne et al26 | IDF | Cross-sectional (urban; type 2 diabetics) | 308 | 55.8 ± 10.5 | Cameroon | 55.7b | 72.1b |
Adeoye et al27 | IDF | Cross-sectional (urban) | 256 | 42.0 ± 9.4 | Nigeria | 17.0 | 14.0 |
Labhardt et al28 | IDF | Cross-sectional (rural) | 1,026 | ≥25 | Lesotho | 9.8 | 22.9 |
Mogre et al29 | IDF | Cross-sectional (urban) | 200 | ≥30 | Ghana | 13.0 | 27.3 |
a. Age range or mean age of participants as provided by the respective journal articles.
b. Age-adjusted MetS prevalence used.
National Cholesterol Education Program; IDF, International Diabetes Federation.
Table 4. Prevalence of metabolic syndrome in South Africa.
Reference | Criteria used | Study design | N | Age,a years | Country | MetS prevalence | |
Male % | Female % | ||||||
Crowther and Norris3 | Harmonized | Cross-sectional (urban) | 1,251 | 18-84 | Soweto, Johannesburg (Black South African) | – | 42.1 |
Schutte and Olckers30 | IDF | Cross-sectional (urban) | 102 | 31.3 ± 8.6 | Potchefstroom (Black South African) | – | 24.8 |
Jennings et al31 | IDF | Cross-sectional (urban) | 225 | 27.0 ± 7.0 | Cape Town (Black South African) | – | 9.9 |
Motala et al2 | Harmonized | Cross-sectional (rural) | 947 | >15 | Kwa–Zulu Natal (Black South African) | 11.6 | 30.2 |
Kalk and Joffe32 | IDF | Cross-sectional (urban; type 2 diabetics) | 500 | >30 | Johannesburg, South Africa | ||
African | 46.5 | 85.2 | |||||
White | 74.1 | 86.6 | |||||
Peer et al4 | Harmonized | Cross-sectional (urban) | 1,099 | 25-74 | Cape Town (Black South African) | 16.5 | 43.0 |
George et al33 | Harmonized | Cross-sectional (urban) | 724 | 18-70 | Soweto, Johannesburg | ||
Black South African | 19.3 | 39.2 | |||||
Indian South African | 55.8 | 37.4 | |||||
Erasmus et al.34 | IDF | Cross-sectional (urban) | 563 | 50.9 ±9.1 | Bellville, Cape Town (mixed ethnic background) | 30.6 | 67.8 |
a. Age range or mean age of participants as provided by the respective journal articles.
IDF, International Diabetes Federation.
Criteria for Diagnosis of Metabolic Syndrome
Currently, the most widely used guideline used for the diagnosis of the MetS is the harmonized one that was proposed in 2009 by various organizations and that suggested synchronizing the various definitions.39 Thus, rather than emphasising one particular component, three or more of the five components need to be present for a positive diagnosis, and region-specific cut-offs for central obesity were proposed (Table 5). The main concern with the harmonized definition is that the waist circumference cut points from White populations are recommended for sub-Saharan Africa due to the lack of African data. However, studies show that the current waist circumference cut point is not appropriate and should be higher in African women.2,3 The aforementioned studies showed that triglyceride levels are low in African populations, and some have suggested that the triglyceride cut point for MetS should be increased in sub-Saharan African populations and African Americans.40,41
Table 5. Criteria used to identify MetS in a population/cohort by means of the harmonized guidelinesa.
Risk factors | Criteria | |
Waist circumference, cm | Male | Female |
Europid and sub-Saharan African | ≥94 | ≥80 |
Asian, Ethnic Central and Southern American, and Japanese | ≥90 | ≥80 |
Chinese | ≥85 | ≥90 |
Triglycerides, mmol/L-1 | ≥1.7 or specific management | |
High–density lipoprotein cholesterol, mmol/L-1 | <1.0 males; <1.30 females | |
Blood pressure, mm Hg | ≥130 systolic and/or ≥85 diastolic or diagnosed hypertension | |
Blood glucose, mmol/L-1 | ≥5.6 or diagnosed diabetes |
a. The harmonized guidelines require the presence of 3 or more of the above 5 criteria for diagnosis of MetS.
Data from studies conducted in various African regions demonstrate that some components of MetS are more prominent in African populations.3,8,42 These studies showed that high waist circumference and low high density lipoprotein cholesterol (HDL) levels are the most prevalent components; this was further confirmed in a recent study of MetS in Black South African women.43
Socioeconomic Status
During the apartheid era, the Black majority were predominantly in the lower socioeconomic stratum and have historically been marginalized with limited access to education, health care, and the ability to earn a sustainable income.44 However, even in the post-apartheid era, the majority of Black South Africans are still living in relatively poorer conditions compared with other population groups, with most not having completed high school.36 Data on the impact of socioeconomic status (SES) on metabolic diseases in South African populations is complex. Some data show a positive association of SES asset index with body fat mass,45 while in other studies, an inverse association with waist circumference and visceral fat was observed.46 Increasing wealth is associated with elevated blood pressure and obesity.47 However in a recent study on the etiology of MetS in mid-life urban South African females, no socioeconomic factors (education and employment) were associated with MetS risk.47
Metabolic and Anthropometric Factors
Visceral fat is the principal anthropometric variable that relates to all the cardiometabolic components of the syndrome,31,48 but in South African studies it has been shown that the visceral depot is lower in African than White females even though the former group is more insulin resistant than the latter.49-51 In a recent study of African women, waist circumference was left out of MetS criteria to uncover the principal determinants of the cardiometabolic components of the syndrome. Visceral fat was found not to correlate with any of the cardiometabolic components but trunk fat-free soft-tissue mass (FFSTM) and abdominal subcutaneous fat were found to positively and negatively modulate risk for the MetS, respectively.43 No previous studies have shown that abdominal subcutaneous fat is a protective factor against MetS and this study demonstrated that this relationship was due to the negative correlation of this variable with fasting glucose levels. Previous studies have shown that subcutaneous abdominal fat is related to a lower risk for type 2 diabetes and that fasting glucose levels are lower in diabetic patients with higher subcutaneous abdominal fat levels.52,53 It is possible that subcutaneous fat may protect against MetS by acting as a reservoir for systemic triglycerides,54 thus preventing their deposition in visceral adipose tissue, skeletal muscle or liver, which then attenuates insulin resistance. The positive association of trunk FFSTM with MetS was a novel finding, and was due to the negative association of FFSTM with HDL levels, as has been observed in two previous studies.55,56 The reason for the negative relationship between FFSTM and HDL levels is not fully understood. However, it has been hypothesized that the liver, which is a major component of the FFSTM measurement from DEXA, can accumulate lipid (hepatic steatosis), which in turn is negatively related to serum HDL levels.57
Adiponectin is an adipose specific secretory product that falls with increasing adiposity,58 via an unknown mechanism. This adipokine is associated with a lower risk of diabetes,59 hypertension,60 and dyslipidemia61 and may therefore be an important role player in the etiology of MetS. Low adiponectin levels were observed to be a strong determinant of MetS risk in African women via the strong negative correlations of serum adiponectin concentrations with triglyceride and glucose levels and a positive correlation with HDL levels.43 In another study, higher concentrations of adiponectin were related to a lower BMI and higher insulin sensitivity in a combined sample of different South African population groups; however, Black patients were found to have lower levels of adiponectin compared with White patients.62 Few data are available on the role of adiponectin in the etiology of MetS in developing countries,63 but a recent study showed that low adiponectin levels were related to a higher risk of MetS independently of insulin resistance, suggesting that low adiponectin levels increase MetS risk independently of its effects on insulin resistance.43
The adipokine leptin is positively associated with fat accumulation.64 In a cross-sectional study of Black South Africans with known coronary artery disease, leptin concentrations were higher in women compared with men, and an association with MetS was demonstrated.65 A number of other South African studies have shown evidence of the correlation of leptin with components of the MetS.66,67 White women have lower leptin levels than Black BMI-matched African women,68 indicating an ethnic variation in the production of this adipokine.69 A positive association between leptin and blood pressure in Black South African women has been observed,70,71 and leptin also correlates with total cholesterol levels.72
Vitamin D deficiency has been associated with cardiometabolic diseases; however, the evidence is inconsistent.73,74 A recent Iranian study noted that vitamin D supplementation improves vitamin D status and lowers triglyceride levels in patients with MetS.75 However, a study by George et al demonstrated that vitamin D status is not linked with MetS risk or its components in Black and Indian South Africans, but parathyroid hormone (PTH) is associated with an increased risk of MetS.33 The association of PTH with MetS was due to its positive correlation with systolic and diastolic blood pressure and waist circumference.
There are many other biomarkers that have been shown to augment the risk of MetS, including inflammatory markers and indicators of oxidative stress.76,77 The association of pro-inflammatory markers and MetS has been confirmed in adolescent Egyptians,78 but this relationship and the link of other biomarkers with MetS needs to be confirmed in adult sub-Saharan African populations.
Physical Activity and Dietary Intake
There is little data on the relationship of physical activity and dietary intake with MetS in African populations; however, some studies have been conducted on the relationship of these factors with obesity and components of the MetS. Thus, data from South Africa show that women living in urban settings have higher sitting times than urban men and rural women,79 and Black African women who met physical activity guidelines have a lower risk of insulin resistance and lower HDL levels compared with inactive women, despite total body weight of the sample having increased in the study period.80 These studies highlight that physical activity is associated with positive health outcomes, and the reverse for sitting time. However, there is a paucity of such studies and more information needs to be generated on the physical activity patterns of women living in African nations.81 A recent study has shown that higher intensity physical activity is associated with better insulin sensitivity in Black South African women.45 This study also observed that walking for transport can result in lower risk of hypercholesterolemia, which is particularly important for women who are sedentary.
The prevalence of obesity is very high in urban, Black South African women and such data suggest that the country is in the advanced stages of a nutritional transition.82 The emergence of cardiometabolic diseases in Black South Africans could be attributable to the adoption of lifestyle behaviors associated with this transition,83 with those in the lower SES stratum consuming cheap, energy-dense foods, predominantly purchased from informal street food vendors.84 Caloric intake of this type has been associated with fat accumulation in Black African women.85
In terms of dietary intake, there are no studies that characterize food intake within African patients with MetS. However, studies have shown that urban Black South African women have sufficient dietary energy intake, but mostly from refined carbohydrates.86 A diet high in carbohydrates is associated with atherogenic dyslipidaemia,87 particularly a lowered HDL concentration and increasing serum triglyceride concentration.88 Moreover, African populations do not consume sufficient fruits and vegetables,89 and compared with rural Black African women, urban-dwelling women consume more total fat, saturated fat and sugar.36
Smoking and Alcohol Intake
A recent study showed that smoking is associated with high MetS risk in Black South African women.43 The association of smoking with MetS was due to its effect on triglyceride levels, confirming the findings of Oh et al.90 Tobacco consumption in South Africans is relatively high in Black males; however, women have a significantly lower prevalence of active smoking.36 The consumption of smokeless tobacco (snuff) is comparatively more popular than cigarette smoking among Black South African women.91 South African snuff has a lower concentration of tobacco-specific N-nitrosamines compared with the majority of products from other countries, but the amount of unionized nicotine in the products is high, allowing for faster absorption rates of nicotine.92 The association of snuff with cardiometabolic diseases seems to be unclear, even though its consumption is associated with increased fat deposition in the visceral adipose depot of African women.46 A study conducted in Sweden has shown a relationship between smokeless tobacco and MetS,93 but this needs to be confirmed in the African context.
Data from the Third National Health and Nutrition Examination Survey showed that alcohol consumption lowers MetS risk in all ethnic groups, but the association is particularly strong in White patients and those who consume a low-moderate amount of alcoholic drinks per month.94 In contrast, Park et al showed that alcohol consumption increases the risk of MetS in male patients, but decreases the risk in women who are heavy consumers of alcohol.95 Alcohol consumption seems to be associated with lower triglyceride levels, high HDL, and lower waist circumference.94 The link between alcohol intake and MetS needs to be analyzed in African women; however, the longitudinal association of a higher alcohol intake with a smaller change in waist circumference over a 10-year period in Black South African women suggests that there may be a link with other components of the MetS.96
Sleep and the Menopause Transition
Sleep duration is another behavioral factor that may contribute to the risk of MetS in African females, but has received far less attention than diet or physical activity. We know that shorter sleep duration (<7 hours per night) is associated with weight gain.97 A recent study has analyzed the relationship of night time sleep duration and day time napping with BMI, waist and blood pressure in Black South African males and females.98 This study demonstrated that in women aged >40 years, there was a significant negative relationship between sleep duration and BMI, while irrespective of age, sleep duration was positively associated with blood pressure, which is a novel finding. In men, day time napping was associated with lower blood pressure and lower waist circumference and BMI. A Korean study showed that both shorter and longer sleep duration (>9 hours per night) are associated with MetS and its components;99 however this has not been confirmed in African populations.
The link between menopausal status and MetS is controversial. Compared with pre-menopausal Ghanian women, post-menopausal women have a significantly higher prevalence of MetS and its components.100 In comparison, a South African cross-sectional study has shown that menopause was not associated with MetS or with any significant change in BMI, but was linked to a fall in lean mass and bone mineral density.46 The latter study notably used the more robust STRAW +10 criteria to define the menopause transition in African women.
Management of Metabolic Syndrome
The primary health care system in South Africa is currently being transformed. The HIV/AIDS epidemic has led to the development of clinic infrastructure that could be expanded for use in treating NCDs.101 In addition, anti-retroviral therapy is associated with an increase in metabolic diseases in African women,102,103 thus making an integrated system of health care a logical approach in the management of patients with multiple morbidities. Data on the prevalence of MetS in HIV-positive Black South African women is limited; however, a study in the Eastern Cape region of South Africa observed a 27% prevalence of MetS in infected African patients using antiretroviral medication.104 Finally, a cohesive effort from public and private institutions is needed to address the increasing prevalence of NCDs in the country, particularly in those communities where current interventions are ineffective in preventing and managing the problem.
Conclusions and Implications
In the context of a global health focus on NCDs, this review has shown that the high prevalence of MetS in Black South African women is influenced by multiple inter-related factors. This represents a major challenge to the transitioning primary health care system in South Africa. A more holistic approach to management of the disease needs to be developed in the midst of persistent social disparities. Community health care workers represent a valuable element of this approach, particularly as the disease can be influenced by patient behavior. Given the background of the population and the resource limitations of the country, cost-effective interventions can help policy makers ensure sustainable management of MetS and related disorders. It is therefore of vital importance that more intervention studies for MetS are performed based on current knowledge to allow the development of effective management policies and programs for Black South Africans.
References
- 1. Ng M, Fleming T, Robinson M, et al. . Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-781. 10.1016/S0140-6736(14)60460-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Motala AA, Esterhuizen T, Pirie FJ, Omar MA. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care. 2011;34(4):1032-1037. 10.2337/dc10-1921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Crowther NJ, Norris SA. The current waist circumference cut point used for the diagnosis of metabolic syndrome in sub-Saharan African women is not appropriate. PLoS One. 2012;7(11):e48883. 10.1371/journal.pone.0048883 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Peer N, Lombard C, Steyn K, Levitt N. High prevalence of metabolic syndrome in the Black population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) study. Eur J Prev Cardiol. 2015;22(8):1036-1042. 10.1177/2047487314549744 [DOI] [PubMed] [Google Scholar]
- 5. Sodjinou R, Agueh V, Fayomi B, Delisle H. Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Public Health. 2008;8(1):84. 10.1186/1471-2458-8-84 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629-636. 10.1161/ATVBAHA.107.151092 [DOI] [PubMed] [Google Scholar]
- 7. Adediran O, Akintunde AA, Edo AE, Opadijo OG, Araoye AM. Impact of urbanization and gender on frequency of metabolic syndrome among native Abuja settlers in Nigeria. J Cardiovasc Dis Res. 2012;3(3):191-196. 10.4103/0975-3583.98890 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007;193(1):70-76. 10.1016/j.atherosclerosis.2006.08.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Osuji CU, Omejua EG. Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients. Indian J Endocrinol Metab. 2012;16(7)(suppl 1):S104-S109. 10.4103/2230-8210.94256 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-1974. 10.1001/jama.2015.4260 [DOI] [PubMed] [Google Scholar]
- 11. Khan SA, Jackson RT. The prevalence of metabolic syndrome among low-income South Asian Americans. Public Health Nutr. 2016;19(3):418-428. 10.1017/S1368980015001330 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia. 2005;48(4):649-656. 10.1007/s00125-005-1689-3 [DOI] [PubMed] [Google Scholar]
- 13. Villegas R, Perry IJ, Creagh D, Hinchion R, O’Halloran D. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care. 2003;26(11):3198-3199. 10.2337/diacare.26.11.3198-a [DOI] [PubMed] [Google Scholar]
- 14. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49(21):2112-2119. 10.1016/j.jacc.2007.01.088 [DOI] [PubMed] [Google Scholar]
- 15. Cameron AJ, Dunstan DW, Owen N, et al. . Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust. 2009;191(4):202-208. [DOI] [PubMed] [Google Scholar]
- 16. Bo S, Gentile L, Ciccone G, et al. . The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21(6):515-524. 10.1002/dmrr.561 [DOI] [PubMed] [Google Scholar]
- 17. Kim YJ. Association of Family Composition and Metabolic Syndrome in Korean Adults Aged over 45 Years Old. Asian Nurs Res (Korean Soc Nurs Sci). 2015;9(4):349-355. Korean Soc Nurs Sci. . PMID:26724245. [DOI] [PubMed]
- 18. Li R, Li W, Lun Z, et al. . Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16(296):296. 10.1186/s12889-016-2870-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Bhowmik B, Afsana F, Siddiquee T, et al. . Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions. J Diabetes Investig. 2015;6(3):280-288. 10.1111/jdi.12268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127-134. 10.1002/dmrr.658 [DOI] [PubMed] [Google Scholar]
- 21. Ozsahin AK, Gokcel A, Sezgin N, et al. . Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab. 2004;17(4):230-234. [PubMed] [Google Scholar]
- 22. Escobedo J, Schargrodsky H, Champagne B, et al. . Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009;8(52):52. 10.1186/1475-2840-8-52 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Akintunde AA, Ayodele OE, Akinwusi PO, Opadijo GO. Metabolic syndrome: comparison of occurrence using three definitions in hypertensive patients. Clin Med Res. 2011;9(1):26-31. 10.3121/cmr.2010.902 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Tran A, Gelaye B, Girma B, et al. . Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;2011:ID 193719. . 10.4061/2011/193719 [DOI] [PMC free article] [PubMed]
- 25. Assah FK, Ekelund U, Brage S, Mbanya JC, Wareham NJ. Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care. 2011;34(2):491-496. 10.2337/dc10-0990 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Kengne AP, Limen SN, Sobngwi E, Djouogo CF, Nouedoui C. Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr. 2012;4(1):22. 10.1186/1758-5996-4-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Adeoye AM, Adewoye IA, Dairo DM, et al. . Excess metabolic syndrome risks among women health workers compared with men. J Clin Hypertens (Greenwich). 2015;17(11):880-884. 10.1111/jch.12595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Labhardt ND, Cheleboi M, Faturyiele O, et al. . Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study. J Int AIDS Soc. 2014;17(4)(suppl 3):19552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Mogre V, Salifu ZS, Abedandi R Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. J Diabetes Metab Disord 2014 Jul 15;13:80. 2014;13:80. [DOI] [PMC free article] [PubMed]
- 30. Schutte AEI I, Olckers A. Metabolic syndrome risk in black South African women compared to Caucasian women. Horm Metab Res. 2007;39(9):651-657. 10.1055/s-2007-985394 [DOI] [PubMed] [Google Scholar]
- 31. Jennings CL, Lambert EV, Collins M, Levitt NS, Goedecke JH. The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution. Metabolism. 2009;58(2):149-157. 10.1016/j.metabol.2008.09.007 [DOI] [PubMed] [Google Scholar]
- 32. Kalk WJ, Joffe BI. The metabolic syndrome, insulin resistance, and its surrogates in African and white subjects with type 2 diabetes in South Africa. Metab Syndr Relat Disord. 2008;6(4):247-255. 10.1089/met.2008.0003 [DOI] [PubMed] [Google Scholar]
- 33. George JA, Norris SA, van Deventer HE, Crowther NJ. The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa. PLoS One. 2013;8(4):e61282. 10.1371/journal.pone.0061282 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Erasmus RT, Soita DJ, Hassan MS, et al. . High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: baseline data of a study in Bellville, Cape Town. S Afr Med J. 2012;102(11 Pt 1):841-844. 10.7196/SAMJ.5670 [DOI] [PubMed] [Google Scholar]
- 35. Nojilana B, Bradshaw D, Pillay-van Wyk V, et al. . Persistent burden from non-communicable diseases in South Africa needs strong action. S Afr Med J. 2016;106(5):23-24. 10.7196/SAMJ.2016.v106i5.10776 [DOI] [PubMed] [Google Scholar]
- 36. Shisana O, Labadarios D, Rehle T, et al. . South African National Health and Nutrition Examination Survey (SANHANES-1). Cape Town: HSRC Press; 2013. [Google Scholar]
- 37. Abubakari AR, Lauder W, Agyemang C, Jones M, Kirk A, Bhopal RS. Prevalence and time trends in obesity among adult West African populations: a meta-analysis. Obes Rev. 2008;9(4):297-311. 10.1111/j.1467-789X.2007.00462.x [DOI] [PubMed] [Google Scholar]
- 38. Seidell JC. Epidemiology of obesity. Semin Vasc Med. 2005;5(1):3-14. 10.1055/s-2005-871737 [DOI] [PubMed] [Google Scholar]
- 39. Alberti KG, Eckel RH, Grundy SM, et al. ; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. 10.1161/CIRCULATIONAHA.109.192644 [DOI] [PubMed] [Google Scholar]
- 40. Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in Black children and adults. J Pediatr 2009;155(3):S7.e7–S7.11. . [DOI] [PMC free article] [PubMed]
- 41. Sumner AE, Harman JL, Buxbaum SG, et al. . The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart Study. Metab Syndr Relat Disord. 2010;8(6):511-514. 10.1089/met.2010.0028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Ntandou G, Delisle H, Agueh V, Fayomi B. Abdominal obesity explains the positive rural-urban gradient in the prevalence of the metabolic syndrome in Benin, West Africa. Nutr Res. 2009;29(3):180-189. 10.1016/j.nutres.2009.02.001 [DOI] [PubMed] [Google Scholar]
- 43. Jean-Luc Gradidge P, Norris SA, Jaff NG, Crowther NJ. Metabolic and body composition risk factors associated with metabolic syndrome in a cohort of women with a high prevalence of cardiometabolic disease. PLoS One. 2016;11(9):e0162247. 10.1371/journal.pone.0162247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Bourne LT, Lambert EV, Steyn K. Where does the black population of South Africa stand on the nutrition transition? Public Health Nutr. 2002;5(1A):157-162. 10.1079/PHN2001288 [DOI] [PubMed] [Google Scholar]
- 45. Gradidge PJ, Crowther NJ, Chirwa ED, Norris SA, Micklesfield LK. Patterns, levels and correlates of self-reported physical activity in urban black Soweto women. BMC Public Health. 2014;14(934):934. 10.1186/1471-2458-14-934 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Jaff NG, Norris SA, Snyman T, Toman M, Crowther NJ. Body composition in the Study of Women Entering and in Endocrine Transition (SWEET): A perspective of African women who have a high prevalence of obesity and HIV infection. Metabolism. 2015;64(9):1031-1041. 10.1016/j.metabol.2015.05.009 [DOI] [PubMed] [Google Scholar]
- 47. Schneider M, Bradshaw D, Steyn K, Norman R, Laubscher R. Poverty and non-communicable diseases in South Africa. Scand J Public Health. 2009;37(2):176-186. 10.1177/1403494808100272 [DOI] [PubMed] [Google Scholar]
- 48. Knight MG, Goedecke JH, Ricks M, et al. . The TG/HDL-C ratio does not predict insulin resistance in overweight women of African descent: a study of South African, African American and West African women. Ethn Dis. 2011;21(4):490-494. [PubMed] [Google Scholar]
- 49. Goedecke JH, Levitt NS, Lambert EV, et al. . Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women. Obesity (Silver Spring). 2009;17(8):1506-1512. 10.1038/oby.2009.73 [DOI] [PubMed] [Google Scholar]
- 50. Evans J, Micklesfield L, Jennings C, et al. . Diagnostic ability of obesity measures to identify metabolic risk factors in South African women. Metab Syndr Relat Disord. 2011;9(5):353-360. 10.1089/met.2011.0034 [DOI] [PubMed] [Google Scholar]
- 51. Sumner AE, Micklesfield LK, Ricks M, et al. . Waist circumference, BMI, and visceral adipose tissue in white women and women of African descent. Obesity (Silver Spring). 2011;19(3):671-674. 10.1038/oby.2010.201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Borel AL, Nazare JA, Smith J, et al. . Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. Int J Obes. 2015;39(3):495-501. 10.1038/ijo.2014.163 [DOI] [PubMed] [Google Scholar]
- 53. Golan R, Shelef I, Rudich A, et al. . Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care. 2012;35(3):640-647. 10.2337/dc11-1583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002;45(9):1201-1210. 10.1007/s00125-002-0873-y [DOI] [PubMed] [Google Scholar]
- 55. Pietrobelli A, Lee RC, Capristo E, Deckelbaum RJ, Heymsfield SB. An independent, inverse association of high-density-lipoprotein-cholesterol concentration with nonadipose body mass. Am J Clin Nutr. 1999;69(4):614-620. [DOI] [PubMed] [Google Scholar]
- 56. Twisk JW, Kemper HC, Mellenbergh GJ, van Mechelen W. Relation between the longitudinal development of lipoprotein levels and biological parameters during adolescence and young adulthood in Amsterdam, The Netherlands. J Epidemiol Community Health. 1996;50(5):505-511. 10.1136/jech.50.5.505 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Cohen DE, Fisher EA. Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. Semin Liver Dis. 2013;33(4):380-388. 10.1055/s-0033-1358519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Motoshima H, Wu X, Sinha MK, et al. . Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002;87(12):5662-5667. 10.1210/jc.2002-020635 [DOI] [PubMed] [Google Scholar]
- 59. Lindsay RS, Funahashi T, Hanson RL, et al. . Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360(9326):57-58. 10.1016/S0140-6736(02)09335-2 [DOI] [PubMed] [Google Scholar]
- 60. Kim DH, Kim C, Ding EL, Townsend MK, Lipsitz LA. Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013;62(1):27-32. 10.1161/HYPERTENSIONAHA.113.01453 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Marso SP, Mehta SK, Frutkin A, House JA, McCrary JR, Kulkarni KR. Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries. Diabetes Care. 2008;31(5):989-994. 10.2337/dc07-2024 [DOI] [PubMed] [Google Scholar]
- 62. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005;37(11):695-701. 10.1055/s-2005-870580 [DOI] [PubMed] [Google Scholar]
- 63. Garg MK, Dutta MK, Mahalle N. Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome. Indian J Endocrinol Metab. 2012;16(1):116-123. 10.4103/2230-8210.91206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Stensel D. Obesity and Diabetes. In: Buckley JP, ed. Exercise Physiology in Special Populations. London: Elsevier Limited; 2008, . 10.1016/B978-0-443-10343-8.00002-0 [DOI] [Google Scholar]
- 65. Ntyintyane L, Panz V, Raal FJ, Gill G. Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease. Metab Syndr Relat Disord. 2009;7(3):243-248. 10.1089/met.2008.0080 [DOI] [PubMed] [Google Scholar]
- 66. Schutte AE, Huisman HW, Schutte R, et al. . Adipokines and cardiometabolic function: how are they interlinked? Regul Pept. 2010;164(2-3):133-138. 10.1016/j.regpep.2010.06.008 [DOI] [PubMed] [Google Scholar]
- 67. Zeelie A, Moss SJ, Kruger HS. The relationship between body composition and selected metabolic syndrome markers in black adolescents in South Africa: the PLAY study. Nutrition. 2010;26(11-12):1059-1064. 10.1016/j.nut.2010.03.001 [DOI] [PubMed] [Google Scholar]
- 68. der Merwe MT, Panz VR, Crowther NJ, et al. . Free fatty acids and insulin levels--relationship to leptin levels and body composition in various patient groups from South Africa. Int J Obes Relat Metab Disord. 1999;23(9):909-917. 10.1038/sj.ijo.0800969 [DOI] [PubMed] [Google Scholar]
- 69. Punyadeera C, van der Merwe M-T, Crowther NJ, Toman M, Schlaphoff GP, Gray IP. Ethnic differences in lipid metabolism in two groups of obese South African women. J Lipid Res. 2001;42(5):760-767. [PubMed] [Google Scholar]
- 70. Schutte AE, van Vuuren D, van Rooyen JM, et al. . Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. J Hum Hypertens. 2006;20(11):850-859. 10.1038/sj.jhh.1002065 [DOI] [PubMed] [Google Scholar]
- 71. Pieterse C, Schutte R, Schutte AE Leptin relates to prolonged cardiovascular recovery after acute stress in Africans: The SABPA study. Nutr Metab Cardiovasc Dis. 2015;pii: S0939–4753(15):30031–30034. [DOI] [PubMed]
- 72. Ayina CNA, Noubiap JJN, Etoundi Ngoa LS, et al. . Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population. Lipids Health Dis. 2016;15(96):96. 10.1186/s12944-016-0264-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28(5):1228-1230. 10.2337/diacare.28.5.1228 [DOI] [PubMed] [Google Scholar]
- 74. Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey . Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-2818. 10.2337/diacare.27.12.2813 [DOI] [PubMed] [Google Scholar]
- 75. Salekzamani S, Mehralizadeh H, Ghezel A, et al. . Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. J Endocrinol Invest. 2016;39(11):1303-1313. 10.1007/s40618-016-0507-8 [DOI] [PubMed] [Google Scholar]
- 76.Report commissioned by the Minister in the Presidency Responsible for Women. Status of women in the South African economy. South Africa: Department of Women: Republic of South Africa;2015.
- 77. Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med. 2005;118(11):1190-1195. 10.1016/j.amjmed.2005.06.046 [DOI] [PubMed] [Google Scholar]
- 78. Aboul Ella NA, Shehab DI, Ismail MA, Maksoud AA. Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipidol. 2010;4(3):185-195. 10.1016/j.jacl.2010.03.007 [DOI] [PubMed] [Google Scholar]
- 79. Cook I, Alberts M, Lambert EV. Influence of cut-points on patterns of accelerometry-measured free-living physical activity in rural and urban black South African women. J Phys Act Health. 2012;9(2):300-310. 10.1123/jpah.9.2.300 [DOI] [PubMed] [Google Scholar]
- 80. Dickie K, Micklesfield LK, Chantler S, Lambert EV, Goedecke JH. Meeting physical activity guidelines is associated with reduced risk for cardiovascular disease in black South African women; a 5.5-year follow-up study. BMC Public Health. 2014;14(1):498. 10.1186/1471-2458-14-498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Guthold R, Ono T, Strong KL, Chatterji S, Morabia A. Worldwide variability in physical inactivity a 51-country survey. Am J Prev Med. 2008;34(6):486-494. 10.1016/j.amepre.2008.02.013 [DOI] [PubMed] [Google Scholar]
- 82. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord. 2004;28(suppl 3):S2-S9. 10.1038/sj.ijo.0802804 [DOI] [PubMed] [Google Scholar]
- 83. Abrahams Z, McHiza Z, Steyn NP. Diet and mortality rates in Sub-Saharan Africa: stages in the nutrition transition. BMC Public Health. 2011;11(1):801. 10.1186/1471-2458-11-801 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Feeley A, Pettifor J, Norris S. Fast-food consumption among 17–year–olds in the Birth to Twenty cohort. South Afr J Clin Nutr. 2009;22(3):118-123. 10.1080/16070658.2009.11734232 [DOI] [Google Scholar]
- 85. Steyn NP, McHiza ZJ. Obesity and the nutrition transition in Sub-Saharan Africa. Ann N Y Acad Sci. 2014;1311(1):88-101. 10.1111/nyas.12433 [DOI] [PubMed] [Google Scholar]
- 86. Joffe YT, van der Merwe L, Evans J, et al. . The tumor necrosis factor-α gene -238G>A polymorphism, dietary fat intake, obesity risk and serum lipid concentrations in black and white South African women. Eur J Clin Nutr. 2012;66(12):1295-1302. 10.1038/ejcn.2012.156 [DOI] [PubMed] [Google Scholar]
- 87. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010;91(3):502-509. 10.3945/ajcn.2008.26285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Shikany JM, Tinker LF, Neuhouser ML, et al. . Association of glycemic load with cardiovascular disease risk factors: the Women’s Health Initiative Observational Study. Nutrition. 2010;26(6):641-647. 10.1016/j.nut.2009.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Peltzer K, Phaswana-Mafuya N. Fruit and vegetable intake and associated factors in older adults in South Africa. Glob Health Action. 2012;5(1):1-8. 10.3402/gha.v5i0.18668 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Oh SW, Yoon YS, Lee ES, et al. ; Korea National Health and Nutrition Examination Survey . Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005;28(8):2064-2066. 10.2337/diacare.28.8.2064 [DOI] [PubMed] [Google Scholar]
- 91. Steyn K, Bradshaw D, Norman R, Laubscher R, Saloojee Y. Tobacco use in South Africans during 1998: the first demographic and health survey. J Cardiovasc Risk. 2002;9(3):161-170. 10.1177/174182670200900305 [DOI] [PubMed] [Google Scholar]
- 92. Stanfill SB, Connolly GN, Zhang L, et al. . Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control. 2011;20(3):e2. 10.1136/tc.2010.037465 [DOI] [PubMed] [Google Scholar]
- 93. Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep’s clothing? Scand J Public Health. 2006;34(6):576-583. 10.1080/14034940600665143 [DOI] [PubMed] [Google Scholar]
- 94. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R; Third National Health and Nutrition Examination Survey . Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2954-2959. 10.2337/diacare.27.12.2954 [DOI] [PubMed] [Google Scholar]
- 95. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-436. 10.1001/archinte.163.4.427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Gradidge PJ, Norris SA, Micklesfield LK, Crowther NJ. The role of lifestyle and psycho-social factors in predicting changes in body composition in Black South African Women. PLoS One. 2015;10(7):e0132914. 10.1371/journal.pone.0132914 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T. Association between weight gain, obesity, and sleep duration: a large-scale 3-year cohort study. Sleep Breath. 2012;16(3):829-833. 10.1007/s11325-011-0583-0 [DOI] [PubMed] [Google Scholar]
- 98. Pretorius S, Stewart S, Carrington MJ, Lamont K, Sliwa K, Crowther NJ. Is there an association between sleeping patterns and other environmental factors with obesity and blood pressure in an urban African population? PLoS One. 2015;10(10):e0131081. 10.1371/journal.pone.0131081 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Choi KM, Lee JS, Park HS, Baik SH, Choi DS, Kim SM. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes. 2008;32(7):1091-1097. 10.1038/ijo.2008.62 [DOI] [PubMed] [Google Scholar]
- 100. Arthur FK, Adu-Frimpong M, Osei-Yeboah J, Mensah FO, Owusu L. The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women. BMC Res Notes. 2013;6(446):446. 10.1186/1756-0500-6-446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374(9693):934-947. 10.1016/S0140-6736(09)61087-4 [DOI] [PubMed] [Google Scholar]
- 102. Goedecke JH, Micklesfield LK, Levitt NS, et al. . Effect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women. AIDS Res Hum Retroviruses. 2013;29(3):557-563. 10.1089/aid.2012.0252 [DOI] [PubMed] [Google Scholar]
- 103. George JA, Venter WD, Van Deventer HE, Crowther NJ. A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses. 2009;25(8):771-781. 10.1089/aid.2008.0308 [DOI] [PubMed] [Google Scholar]
- 104. Awotedu K, Ekpebegh C, Longo-Mbenza B, Iputo J. Prevalence of metabolic syndrome assessed by IDF and NCEP ATP 111 criteria and determinants of insulin resistance among HIV patients in the Eastern Cape Province of South Africa. Diabetes Metab Syndr. 2010;4(4):210-214. 10.1016/j.dsx.2010.09.002 [DOI] [Google Scholar]